Chicago Atlantic Real Estate Finance (REFI) has emerged as a safe haven for investors in the fluctuating cannabis market. Despite broader market downturns, REFI has demonstrated robust growth and maintained consistent dividend payouts, showcasing its resilience and attractiveness as a high-yield, low-volatility investment.
Greenway Greenhouse Cannabis Corporation (GWAY, GWAYF) announced record financial results for the first quarter of 2024, with a 104% year-over-year increase in net revenue and positive adjusted EBITDA. The company attributes its success to its focus on producing high-quality cannabis, optimizing production costs, and expanding its distribution channels.
With the 2024 election potentially featuring the first pro-cannabis legalization presidential ticket in U.S. history, industry experts are optimistic about potential advancements in federal cannabis policy. While acknowledging legislative challenges, experts highlight the potential for executive actions and bipartisan support to push cannabis reform forward.
As the 2024 election approaches, the Biden-Harris administration has urged the DEA to make a decision on cannabis rescheduling. However, experts like Barbara Fox, CEO of Cannabiz Supply, believe that any decision made before the election could be perceived as politically motivated, potentially delaying the process. Fox also discusses the potential economic implications of rescheduling, including increased mergers and acquisitions and greater access to traditional banking.
Stiiizy, a leading cannabis brand in California, is facing a barrage of legal challenges despite its success in the state’s competitive market. The company is accused of various legal violations, including defrauding customers, illegal sales across state lines, and distributing cannabis with dangerous pesticides. While Stiiizy denies these claims and maintains its dominance, the lawsuits could significantly impact its future.
Mothers of children with epilepsy in Brazil have been instrumental in advocating for the legalization and free access to cannabidiol (CBD)-based medicines. Their decade-long fight has resulted in groundbreaking changes in São Paulo, where CBD-based medicines are now available free of charge in public and private health facilities. This victory is a testament to their unwavering commitment to their children’s health and the potential of CBD as a life-saving treatment.
As Ohio’s adult-use cannabis market flourishes, a notable career shift is emerging. Individuals aged 30 to 50, primarily from Gen X and millennial generations, are increasingly drawn to the cannabis industry for new job opportunities. This trend is fueled by the growth of specialized training programs and the promise of a thriving local economy.
With the potential rescheduling of cannabis at the federal level, industry experts are analyzing the implications for the financial landscape of cannabis businesses. This article explores the potential benefits and challenges of rescheduling, including access to traditional banking, capital markets, and the impact on federal tax provisions. It also highlights the perspective of Laurie Parfitt, a leading cannabis industry expert.
Decibel Cannabis Co. (DBCCF), a Canadian cannabis brand, is experiencing challenges in its core market segments, but is making strategic adjustments to regain market share. Despite recent sales declines, the company’s management is focused on stabilizing its core franchises and growing through a strategic re-entry into domestic recreational flower markets and increased exports. This strategic shift, combined with its compelling valuation, makes Decibel Cannabis an intriguing investment opportunity.
Canadian cannabis producer Entourage Health Corp. reported a decrease in revenue for the second quarter of 2024, citing new product launches and restructuring efforts. The company remains optimistic about future growth and is focused on expanding distribution channels and strategic partnerships.
